Showing results (91-100 of 204) with videos related to
Sort By:
Pageof 21
Clinical and Experimental Immunology|May 1, 1991
Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patientsM Opravil, W Fierz, L Matter, et al.BMJ (Clinical Research Ed.)|December 15, 1990
Progression of HIV infection in misusers of injected drugs who stop injecting or follow a programme of maintenance treatment with methadoneR Weber, B Ledergerber, M Opravil, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 23, 1998
Antibody response in six HACEK endocarditis cases under therapyR Zbinden, A Hany, R Lüthy, et al.International Journal of Antimicrobial Agents|December 19, 2000
Use of HIV-1 p24 as a sensitive, precise and inexpensive marker for infection, disease progression and treatment failureJ Schüpbach, Z Tomasik, D Nadal, et al.AIDS Care|November 25, 2000
A continuing concern: HIV and hepatitis testing and prevalence among drug users in substitution programmes in Zurich, SwitzerlandB Somaini, J Wang, M Perozo, et al.Blut|November 1, 1990
Inferior vena cava thrombosis in a child with nephroblastoma and combined deficiency of antithrombin III and free protein SF Demarmels, A R Lüthy, A Hirt, et al.Pediatric Research|May 8, 1999
In childhood acute lymphoblastic leukemia the hypophosphorylated retinoblastoma protein, p110RB, is diminished, as compared with normal CD34+ peripheral blood progenitor cellsK Leibundgut, N Schmitz, A Tobler, et al.Antimicrobial Agents and Chemotherapy|December 1, 1995
Monitoring of co-trimoxazole concentrations in serum during treatment of pneumocystis carinii pneumoniaB Joos, J Blaser, M Opravil, et al.The Journal of Antimicrobial Chemotherapy|November 1, 1995
Nephrotoxicity, high frequency ototoxicity, efficacy and serum kinetics of once versus thrice daily dosing of netilmicin in patients with serious infectionsJ Blaser, H P Simmen, U Thurnheer, et al.Pageof 21